4.8 (441) In stock
PDF) Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study
PDF) Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease: A Retrospective Database Analysis
PDF) Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV‐50717) Compared With Tetrabenazine in Healthy Volunteers
Laura RABINOVICH-GUILATT, Sr Dir, Doctor of Philosophy, Teva Pharmaceutical Industries Ltd., Petah Tikva, TEVA, Clinical Pharmacology and Pharmacometrics
Maria Sunzel - Teva Pharmaceuticals
Laura RABINOVICH-GUILATT, Sr Dir, Doctor of Philosophy, Teva Pharmaceutical Industries Ltd., Petah Tikva, TEVA, Clinical Pharmacology and Pharmacometrics
Laura RABINOVICH-GUILATT, Sr Dir, Doctor of Philosophy, Teva Pharmaceutical Industries Ltd., Petah Tikva, TEVA, Clinical Pharmacology and Pharmacometrics
AAN banner.jpg
PDF) Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington's Disease: A Retrospective Database Analysis
Edward Hellriegel - Teva Pharmaceuticals
Dose-Normalized Pharmacokinetic Parameters for the Active HTBZ
